AJNR Am J Neuroradiol

1. DIZDAR N, Soni N, Johnson DR, Kendi AT, et al
   Beyond FDG PET in Epilepsy: Radiotracers Targeting Neuroreceptors and Neural Proteins.
   AJNR Am J Neuroradiol. 2026 Jul 1:ajnr.A9508. doi: 10.3174/ajnr.A9508.
   

   >> Share

   
   

   
   Ann Nucl Med

2. CHEN X, Peng Y, Zheng Q, Lai Y, et al
   The Prognostic Value of (68)Ga-PSMA and (18)F-FDG PET/CT in Metastatic Castration-Resistant Prostate Cancer Treated with (177)Lu-EB-PSMA.
   Ann Nucl Med. 2026 Jul 1. doi: 10.1007/s12149-026-02250.
   

   >> Share

   
   
3. TOMIYAMA A, Iwabuchi Y, Tonda K, Owaki Y, et al
   Impact of biguanide therapy on hepatic (18)F-fluorodeoxyglucose-positron emission tomography quantitative parameters in patients with diabetes: a dynamic positron emission tomography study.
   Ann Nucl Med. 2026 Jun 29. doi: 10.1007/s12149-026-02251.
   

   >> Share

   
   
4. BOSQUE JJ, Molina-Garcia D, Perez-Beteta J, Vicente AMG, et al
   Complementary prognostic value of hotspot-to-centroid distance (NHOCpeak) to SUVpeak in high-grade glioma.
   Ann Nucl Med. 2026;40:373-383.
   

   >> Share

   
   
5. YAMAKUNI R, Ukon N, Kanezawa T, Ishikawa H, et al
   Effect of magnetic resonance image-based motion correction on the centiloid scale: a comparison with and without correction.
   Ann Nucl Med. 2026;40:552-563.
   

   >> Share

   
   
6. WATANABE S, Hirata K, Takenaka J, Munakata Y, et al
   Somatostatin receptor expression for peptide receptor radionuclide therapy in Japanese patients with recurrent or metastatic differentiated thyroid cancer.
   Ann Nucl Med. 2026;40:539-551.
   

   >> Share

   
   
7. BOOIJ J, Chahid Y, Reits EA, Gether U, et al
   The radiotracer [(123)I]I-FP-CIT binds preferentially to the dopamine transporter expressed at the plasma membrane of nigrostriatal dopaminergic neurons: a new concept.
   Ann Nucl Med. 2026;40:101-107.
   

   >> Share

   
   

   
   BMC Neurol

8. HAN Y, Qiu M, Wu J, Cheng L, et al
   Amelanotic primary thalamic melanoma: a case report.
   BMC Neurol. 2026;26:294.
   

   >> Share

   
   
9. KAWAI S, Kobayashi R, Sakamoto K, Nemoto K, et al
   Suicide attempt by a patient with an early phase of progressive supranuclear palsy: a case report.
   BMC Neurol. 2026;26:184.
   

   >> Share

   
   

   
   Clin Nucl Med

10. FAN M, Yao Z, Guo X, Hu M, et al
    Posttreatment (6)(8)Ga-FAP-2286 PET/CT Parameters for Response and Survival Assessment After (1)(7)(7)Lu-FAP-2286 Radioligand Therapy in Advanced Solid Tumors.
    Clin Nucl Med. 2026 Jul 3. doi: 10.1097/RLU.0000000000006588.
    

    >> Share

    
    
11. ZHAO G, Wang Y, Wu Y, Zhao X, et al
    18F-FDG PET/CT Imaging of Multiple Inflammatory Myofibroblastic Tumors.
    Clin Nucl Med. 2026 Jul 1. doi: 10.1097/RLU.0000000000006604.
    

    >> Share

    
    
12. HUANG X, Guo X, Li B, Yang H, et al
    A Prospective Head-to-Head Comparison of HER2-Targeted and 18F-FDG PET/CT for Detecting Axillary Lymph Node Metastases Among Newly Diagnosed HER2-Positive and HER2-Low Breast Cancer.
    Clin Nucl Med. 2026 Jun 29. doi: 10.1097/RLU.0000000000006564.
    

    >> Share

    
    
13. PEROZZIELLO F, Renaud M, Cousin S, Prega-Renaud V, et al
    Epileptogenic Brain Metastasis Early Positive on 18FDG PET/CT Compared to MRI.
    Clin Nucl Med. 2026 Jun 29. doi: 10.1097/RLU.0000000000006530.
    

    >> Share

    
    
14. WU C, Fu Z
    Malignant Perivascular Epithelioid Cell Tumor (PEComa) of Left Adrenal Gland With Extensive Intravenous Tumor Thrombi: 18F-FDG PET/CT Findings.
    Clin Nucl Med. 2026 Jun 26. doi: 10.1097/RLU.0000000000006593.
    

    >> Share

    
    

    
    Hum Brain Mapp

15. ZHOU J, Xu Y, Li T, Yang X, et al
    Neural Correlates of Explicit Outcome Expectation Effects: An Activation Likelihood Estimation Meta-Analysis.
    Hum Brain Mapp. 2026;47:e70594.
    

    >> Share

    
    

    
    IEEE Trans Med Imaging

16. JIN Y, Ran H, Ning G, Su X, et al
    Physiology-guided Self-supervised Learning for Simultaneous Dual-Tracer PET Separation.
    IEEE Trans Med Imaging. 2026;PP.
    

    >> Share

    
    

    
    J Cereb Blood Flow Metab

17. GROGER R, Englert AL, Lalia M, de Weerd L, et al
    Assessment of early-phase [(18)F]florbetaben images as a proxy for brain metabolism in mouse models of Alzheimer's disease.
    J Cereb Blood Flow Metab. 2026 Mar 10:271678X261420082.
    

    >> Share

    
    

    
    J Nucl Cardiol

18. LV Y, Zheng D, Zhou Z, Dai Z, et al
    Clinical Application and Research Advances of PET Molecular Imaging in Immune Checkpoint Inhibitor-Associated Myocarditis.
    J Nucl Cardiol. 2026 Jul 3:102798. doi: 10.1016/j.nuclcard.2026.102798.
    

    >> Share

    
    
19. LIE W, Djafari Rouhani S, Clark L, Divakaran S, et al
    Immuno-PET in Cardiovascular Disease: Advances, Challenges, and Opportunities.
    J Nucl Cardiol. 2026 Jul 2:102800. doi: 10.1016/j.nuclcard.2026.102800.
    

    >> Share

    
    
20. O'GORMAN KJ, Bremner L, Mian Z, Yang L, et al
    Normal Values for (13)N-Ammonia PET-derived Metrics in Heart Transplant Patients.
    J Nucl Cardiol. 2026 Jun 30:102797. doi: 10.1016/j.nuclcard.2026.102797.
    

    >> Share

    
    

    
    J Nucl Med

21. HEKIMSOY T, Sauter AP, Tauber R, Horn T, et al
    Toward a Biopsy-Free Diagnosis of Prostate Cancer: Potential of Combined (18)F-Flotufolastat PSMA PET and mpMRI.
    J Nucl Med. 2026 Jul 2:jnumed.125.271916. doi: 10.2967/jnumed.125.271916.
    

    >> Share

    
    
22. FAROLFI A, Sgro CMP, Brusa I, Dall'Olio D, et al
    PSMA PET/CT-Targeted Biopsy in Men with Negative or Equivocal Multiparametric MRI and Exploratory Dynamic Total-Body PET: The FUPERMAN Study.
    J Nucl Med. 2026 Jul 2:jnumed.126.272108. doi: 10.2967/jnumed.126.272108.
    

    >> Share

    
    
23. DUAN S, Tan B, Mao Y, Zhang Y, et al
    ICOS-Targeted Peptide Imaging Informs Therapeutic Response of STING Agonist in Lung Adenocarcinoma.
    J Nucl Med. 2026;67:1062-1069.
    

    >> Share

    
    
24. ELLS Z, Meyer C, Kimura K, Wilhalme H, et al
    Dosimetry Analysis of (177)Lu-PSMA-I&T in Patients with Low-Volume Oligometastatic Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the LUNAR Trial.
    J Nucl Med. 2026 Apr 2:jnumed.125.271467. doi: 10.2967/jnumed.125.271467.
    

    >> Share

    
    
25. SONG H, Xiang Z, Wang Y, Zhao J, et al
    First Total-Body Kinetics Study of (18)F-Flurpiridaz in Healthy Volunteers at Rest and Feasibility of Simplified Quantitative Strategies.
    J Nucl Med. 2026;67:1148-1155.
    

    >> Share

    
    

    
    Neurology

26. GOLDSTEIN DS
    Putamen Dopamine Synthesis, Vesicular Storage, and Metabolism in Patients With Parkinson Disease.
    Neurology. 2026;107:e218226.
    

    >> Share

    
    

    
    Nucl Med Commun

27. ABDELNAIM AKM, Shehata S, Mekkawy N, Eloteify LM, et al
    Diagnostic performance and quantitative characterization of PET/computed tomography in peritoneal deposits assessment.
    Nucl Med Commun. 2026 Jun 30. doi: 10.1097/MNM.0000000000002204.
    

    >> Share

    
    

    
    Phys Med Biol

28. EVANS B, Kuo HT, Joseph J, Barcena AJR, et al
    Quantitative perfusion imaging from non-contrast micro-ct for pulmonary embolism evaluation in preclinical models.
    Phys Med Biol. 2026;71:135018.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share